Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

Clinical trial NCT02260544 · COMPLETED

Trial details

NCT number: NCT02260544
Sponsor: Dr. Reddy's Laboratories Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Epithelial Cancer Recurrent

Start date: 2014-07-01
Primary completion: 2015-04-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.